Reents Scott T — SEC Form 4 filings
SEC reporting owner CIK 1937048. 7 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-20 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 31,784 shares, $6,255,529 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 17,644 shares @ $212.34 ($3,746,527) in AbbVie Inc., filed 2025-03-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | EVP, CHIEF FINANCIAL OFFICER | 7 | — | 2 legs · 31,784 sh · $6,255,529 | 20 |
Form 4 filings — Reents Scott T
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-03 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 21,638 @ $232.08 | EDGAR |
| 2026-02-20 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 25,062 @ $0 · Grant/award (A): 8,910 @ $0 · Grant/award (A): 7,606 @ $0 · Grant/award (A): 7,260 @ $0 · Grant/award (A): 21,937 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | AbbVie Inc. (ABBV) | Sale (S): 17,644 @ $212.34 | EDGAR |
| 2025-03-04 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 10,973 @ $205.02 | EDGAR |
| 2025-02-18 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 5,845 @ $0 · Grant/award (A): 2,398 @ $0 · Grant/award (A): 8,912 @ $0 · Grant/award (A): 7,608 @ $0 · Grant/award (A): 27,343 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | AbbVie Inc. (ABBV) | Option exercise (M): 14,140 @ $61.36 · Sale (S): 14,140 @ $177.44 · Tax withholding (F): 11,634 @ $178.99 · Option exercise (M): 14,140 (derivative) @ $61.36 | EDGAR |
| 2024-02-20 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 11,800 @ $0 · Grant/award (A): 3,146 @ $0 · Grant/award (A): 2,398 @ $0 · Grant/award (A): 8,912 @ $0 · Grant/award (A): 31,520 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1937048 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →